KALY – Kali-Extracts CEO Reminds Shareholders They Own Stock In A Cannabis Biopharmaceutical Company With GW Pharmaceuticals Potential
The company is executing on simple CBD extraction business strategies to sustain its primary biopharmaceutical development objectives.
Read More
